| Trial ID: | L3810 |
| Source ID: | NCT03193944
|
| Associated Drug: |
D-Vitin, Soft Gelatin Capsule (Vitamin D3,50000 Iu)
|
| Title: |
Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Vitamin D Deficiency|Diabetes Mellitus|Hypertension|Lipid Metabolism Disorders|Obesity, Abdominal
|
| Interventions: |
DRUG: D-vitin, soft gelatin capsule (vitamin D3,50000 IU)|DRUG: Placebo vitamin D3
|
| Outcome Measures: |
Primary: Achieving 25 (OH) D upper than insufficient serum 25(OH) D level >30 ng/l., According to the guidline, vitamin D deficiency will improve by taking vitamin D3 by 2 months., by 2 months | Secondary: Reduction anthropometry (BMI and WC),, Reduction of BMI, WC after 2 months intervention by vitamin D3, by 2 months|Improved Biomarker indicators (lipid profile), Reduction of lipid profiles are important for this research after vitamin D3 intervention., by 2 months|Improved Biomarker indicator FBS, Reduction of FBS by 2 months intervention via taking vitamin D, by 2 months|Improved blood pressure, Reduction of blood pressure after taking vitamin D for 2 months, by 2 months
|
| Sponsor/Collaborators: |
Sponsor: Alborz Medical University | Collaborators: Universiti Putra Malaysia
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2017-02-10
|
| Completion Date: |
2017-07-10
|
| Results First Posted: |
|
| Last Update Posted: |
2018-01-16
|
| Locations: |
Maryam Zarei, Karaj, Alborz, Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT03193944
|
